• Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead Realasset Realasset
moneycontrol.com

Home » News » Business

Mar 28, 2013, 12.58 PM | Source: Moneycontrol.com

Aurobindo Pharma jumps as FDA removes Unit VI import ban

Shares of Aurobindo Pharma surged more than 8 percent on Thursday after it said the US Food and Drug Administration has lifted the import alert for non-sterile products manufactured in its unit VI cephalosporin facility in Hyderabad, Andhra Pradesh.

Like this story, share it with millions of investors on M3

Aurobindo Pharma jumps as FDA removes Unit VI import ban

Shares of Aurobindo Pharma surged more than 8 percent on Thursday after it said the US Food and Drug Administration has lifted the import alert for non-sterile products manufactured in its unit VI cephalosporin facility in Hyderabad, Andhra Pradesh.

Post Your Comments

Share Cancel

Moneycontrol Bureau

Shares of Aurobindo Pharma surged more than 8 percent on Thursday after it said the US Food and Drug Administration has lifted the import alert for non-sterile products manufactured in its unit VI cephalosporin facility in Hyderabad, Andhra Pradesh.

This will pave the way for resuming exports of 9 products to the US market from the plant, the drug maker said.

The production facility that makes the anti-bacterial drug was audited by the USFDA in December 2010 and the drug regulator had issued an import alert in Feb 2011.

The unit had annual sales of USD 33 million prior to the import alert, Aurobindo said.

At 11:45 hrs, Aurobindo shares were up 8.9 percent at Rs 142.10 on NSE.

Aurobindo Pharm stock price

On February 10, 2016, Aurobindo Pharma closed at Rs 691.75, down Rs 51.55, or 6.94 percent. The 52-week high of the share was Rs 891.50 and the 52-week low was Rs 490.50.


The company's trailing 12-month (TTM) EPS was at Rs 26.48 per share as per the quarter ended December 2015. The stock's price-to-earnings (P/E) ratio was 26.12. The latest book value of the company is Rs 94.54 per share. At current value, the price-to-book value of the company is 7.32.

Ads by Google

Buy, Hold, Sell ? Hear it first on M3
Aurobindo Pharma jumps as FDA removes Unit VI import ban

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login